Related Experiment Video
Updated: May 5, 2026
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
[Prevention and treatment of major bleeding during anticoagulation]
Masahiro Yasaka1, Yasushi Okada
1Cerevrovascular Medicine and Neurology, Cerebrovascular Center, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center.
Insights
Managing controllable risk factors and avoiding dual antithrombotic therapy are crucial for preventing major hemorrhage during anticoagulation. Prompt intervention, including stopping medication and reversing anticoagulation with prothrombin complex concentrate (PCC), is vital for patients experiencing bleeding events.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Pharmacology
Context:
- Anticoagulation therapy is essential for preventing thrombotic events but carries a risk of major hemorrhage.
- Managing modifiable risk factors like hypertension, diabetes, smoking, and alcohol consumption is key to mitigating bleeding risks.
- Dual antithrombotic therapy significantly increases the incidence of severe bleeding events.
Purpose:
- To outline strategies for preventing and managing major hemorrhage in patients undergoing anticoagulation.
- To highlight the importance of risk factor management and appropriate therapeutic interventions.
Summary:
- Preventing major hemorrhage involves controlling risk factors (hypertension, diabetes, smoking, alcohol) and minimizing dual antithrombotic therapy.
- Management of major bleeding includes stopping oral anticoagulants, controlling hemorrhage via mechanical or surgical means, and maintaining hemodynamic stability.
- Intracranial hemorrhage requires prompt blood pressure reduction. Prothrombin complex concentrate (PCC) and vitamin K are effective for urgent warfarin reversal and may benefit novel oral anticoagulant-associated bleeding.
Impact:
- Provides practical guidance for clinicians to reduce anticoagulation-related bleeding complications.
- Emphasizes a proactive approach to patient safety in anticoagulation management.
- Informs treatment protocols for managing severe bleeding, including specific interventions for intracranial hemorrhage and reversal strategies.
Abstract:
To prevent major hemorrhage during anticoagulation, it is quite important to manage controllable risk factors such as hypertension, diabetes mellitus, smoking habit, and too much alcohol intake. It is also important to avoid dual antithrombotic therapy as long as possible, which increases severe bleeding events. For patients with major bleeding during anticoagulation, we should stop oral medication, stop bleeding by mechanical compression or surgical interventions, and maintain circulation blood volume and blood pressure by appropriate intravenous drip infusion. When intracranial hemorrhage happens, adequate treatment to suppress blood pressure should be provided. Administration of prothrombin complex concentrate (PCC) and vitamin K is effective for urgent reversal of anticoagulation by warfarin. The PCC may be also useful for that by novel oral anticoagulants.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:30Venous Thrombosis IV: Nursing Management
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.